BIO-key International Competitors

Cisco Systems (NASDAQ:CSCO) and BIO-key International (NASDAQ:BKYI) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership.

Analyst Ratings

This is a summary of current recommendations for Cisco Systems and BIO-key International, as provided by MarketBeat.

Cisco Systems currently has a consensus target price of $50.7391, suggesting a potential downside of 5.62%. BIO-key International has a consensus target price of $6.00, suggesting a potential upside of 79.10%. Given BIO-key International's stronger consensus rating and higher possible upside, analysts plainly believe BIO-key International is more favorable than Cisco Systems.

Profitability

This table compares Cisco Systems and BIO-key International's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Cisco Systems and BIO-key International's top-line revenue, earnings per share and valuation.

Cisco Systems has higher revenue and earnings than BIO-key International.

Institutional & Insider Ownership

70.6% of Cisco Systems shares are owned by institutional investors. Comparatively, 29.2% of BIO-key International shares are owned by institutional investors. 0.0% of Cisco Systems shares are owned by company insiders. Comparatively, 8.8% of BIO-key International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Risk and Volatility

Cisco Systems has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Comparatively, BIO-key International has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500.

Summary

Cisco Systems beats BIO-key International on 8 of the 13 factors compared between the two stocks.

International Business Machines (NYSE:IBM) and BIO-key International (NASDAQ:BKYI) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, risk and earnings.

Volatility and Risk

International Business Machines has a beta of 1.25, suggesting that its stock price is 25% more volatile than the S&P 500. Comparatively, BIO-key International has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500.

Profitability

This table compares International Business Machines and BIO-key International's net margins, return on equity and return on assets.

Institutional and Insider Ownership

55.7% of International Business Machines shares are owned by institutional investors. Comparatively, 29.2% of BIO-key International shares are owned by institutional investors. 0.2% of International Business Machines shares are owned by company insiders. Comparatively, 8.8% of BIO-key International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current recommendations and price targets for International Business Machines and BIO-key International, as provided by MarketBeat.com.

International Business Machines presently has a consensus target price of $148.4444, indicating a potential upside of 0.48%. BIO-key International has a consensus target price of $6.00, indicating a potential upside of 79.10%. Given BIO-key International's stronger consensus rating and higher possible upside, analysts plainly believe BIO-key International is more favorable than International Business Machines.

Earnings & Valuation

This table compares International Business Machines and BIO-key International's top-line revenue, earnings per share and valuation.

International Business Machines has higher revenue and earnings than BIO-key International.

Summary

International Business Machines beats BIO-key International on 9 of the 13 factors compared between the two stocks.

BIO-key International (NASDAQ:BKYI) and HP (NYSE:HPQ) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk.

Analyst Ratings

This is a summary of current recommendations for BIO-key International and HP, as provided by MarketBeat.com.

BIO-key International presently has a consensus target price of $6.00, suggesting a potential upside of 79.10%. HP has a consensus target price of $24.4643, suggesting a potential downside of 31.43%. Given BIO-key International's stronger consensus rating and higher possible upside, research analysts plainly believe BIO-key International is more favorable than HP.

Volatility & Risk

BIO-key International has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Comparatively, HP has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500.

Profitability

This table compares BIO-key International and HP's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares BIO-key International and HP's gross revenue, earnings per share and valuation.

HP has higher revenue and earnings than BIO-key International.

Institutional and Insider Ownership

29.2% of BIO-key International shares are owned by institutional investors. Comparatively, 80.6% of HP shares are owned by institutional investors. 8.8% of BIO-key International shares are owned by insiders. Comparatively, 0.3% of HP shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

HP beats BIO-key International on 9 of the 13 factors compared between the two stocks.

BIO-key International (NASDAQ:BKYI) and Arista Networks (NYSE:ANET) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings.

Volatility and Risk

BIO-key International has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, Arista Networks has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and recommmendations for BIO-key International and Arista Networks, as provided by MarketBeat.com.

BIO-key International presently has a consensus target price of $6.00, suggesting a potential upside of 79.10%. Arista Networks has a consensus target price of $338.5263, suggesting a potential upside of 2.19%. Given BIO-key International's stronger consensus rating and higher probable upside, equities analysts plainly believe BIO-key International is more favorable than Arista Networks.

Profitability

This table compares BIO-key International and Arista Networks' net margins, return on equity and return on assets.

Valuation and Earnings

This table compares BIO-key International and Arista Networks' top-line revenue, earnings per share (EPS) and valuation.

Arista Networks has higher revenue and earnings than BIO-key International.

Institutional and Insider Ownership

29.2% of BIO-key International shares are held by institutional investors. Comparatively, 61.8% of Arista Networks shares are held by institutional investors. 8.8% of BIO-key International shares are held by insiders. Comparatively, 23.8% of Arista Networks shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Arista Networks beats BIO-key International on 10 of the 13 factors compared between the two stocks.

F5 Networks (NASDAQ:FFIV) and BIO-key International (NASDAQ:BKYI) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, earnings, risk, valuation, institutional ownership and profitability.

Profitability

This table compares F5 Networks and BIO-key International's net margins, return on equity and return on assets.

Volatility & Risk

F5 Networks has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, BIO-key International has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for F5 Networks and BIO-key International, as provided by MarketBeat.com.

F5 Networks currently has a consensus price target of $203.8571, indicating a potential upside of 10.75%. BIO-key International has a consensus price target of $6.00, indicating a potential upside of 79.10%. Given BIO-key International's stronger consensus rating and higher probable upside, analysts clearly believe BIO-key International is more favorable than F5 Networks.

Insider & Institutional Ownership

90.7% of F5 Networks shares are held by institutional investors. Comparatively, 29.2% of BIO-key International shares are held by institutional investors. 0.3% of F5 Networks shares are held by insiders. Comparatively, 8.8% of BIO-key International shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares F5 Networks and BIO-key International's revenue, earnings per share (EPS) and valuation.

F5 Networks has higher revenue and earnings than BIO-key International.

Summary

F5 Networks beats BIO-key International on 9 of the 13 factors compared between the two stocks.

Juniper Networks (NYSE:JNPR) and BIO-key International (NASDAQ:BKYI) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends.

Profitability

This table compares Juniper Networks and BIO-key International's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Juniper Networks and BIO-key International, as reported by MarketBeat.com.

Juniper Networks currently has a consensus target price of $25.50, indicating a potential downside of 6.59%. BIO-key International has a consensus target price of $6.00, indicating a potential upside of 79.10%. Given BIO-key International's stronger consensus rating and higher probable upside, analysts plainly believe BIO-key International is more favorable than Juniper Networks.

Valuation & Earnings

This table compares Juniper Networks and BIO-key International's top-line revenue, earnings per share (EPS) and valuation.

Juniper Networks has higher revenue and earnings than BIO-key International.

Insider & Institutional Ownership

89.3% of Juniper Networks shares are held by institutional investors. Comparatively, 29.2% of BIO-key International shares are held by institutional investors. 1.2% of Juniper Networks shares are held by insiders. Comparatively, 8.8% of BIO-key International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Volatility and Risk

Juniper Networks has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500. Comparatively, BIO-key International has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500.

Summary

Juniper Networks beats BIO-key International on 8 of the 13 factors compared between the two stocks.